FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 598 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR How Anxiety Impacts People With Cancer and How to Cope February 10, 2022 ESMO World Congress on Gastrointestinal Cancer 2020 June 22, 2020 Better EFS Outcomes with Perioperative Durvalumab Plus FLOT Than with Placebo... June 10, 2025 Pioneer in Autism Diagnosis And Treatment Dies At 97 September 21, 2021 Load more HOT NEWS Partnership in a pandemic: how Credit Suisse delivered an incredible Charity... PARP Inhibitors Show Promise as Initial Treatment for Ovarian Cancer Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer EMA Recommends Granting a Marketing Authorisation for Quizartinib
